NFKB1 and cancer: In cancer cells, activation of inflammatory pathways such as NF-κB-signaling, either induced by acute inflammatory processes or constitutively activated, can induce a pro-tumorigenic response, such as cell survival, controlling epithelial-mesenchymal-transition and metastasis30.